Andrew L. Finn
2014
In 2014, Andrew L. Finn earned a total compensation of $1.8M as Executive VP of Product Development at BioDelivery Sciences International, a 61% increase compared to previous year.
Compensation breakdown
| Bonus | $124,140 |
|---|---|
| Salary | $307,013 |
| Stock Awards | $1,365,995 |
| Other | $38,958 |
| Total | $1,836,106 |
Finn received $1.4M in stock awards, accounting for 74% of the total pay in 2014.
Finn also received $124.1K in bonus, $307K in salary and $39K in other compensation.
Rankings
In 2014, Andrew L. Finn's compensation ranked 4,872nd out of 13,032 executives tracked by ExecPay. In other words, Finn earned more than 62.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,872 out of 13,032 | 63rd |
Division Manufacturing | 1,741 out of 4,965 | 65th |
Major group Chemicals And Allied Products | 571 out of 1,690 | 66th |
Industry group Drugs | 435 out of 1,369 | 68th |
Industry Pharmaceutical Preparations | 346 out of 1,042 | 67th |
Source: SEC filing on May 12, 2016.
Finn's colleagues
We found six more compensation records of executives who worked with Andrew L. Finn at BioDelivery Sciences International in 2014.
2014
Mark Sirgo
BioDelivery Sciences International
Chief Executive Officer
2014
Mark SirgoPharmD
BioDelivery Sciences International
Chief Executive Officer
2014
Andrew FinnPharmD
BioDelivery Sciences International
Executive VP of Product Development
2014
Niraj Vasisht
BioDelivery Sciences International
Chief Technology Officer
2014
Ernest De Paolantonio
BioDelivery Sciences International
Chief Financial Officer
2014
Ernest De PaolantonioCPA
BioDelivery Sciences International